International Travel

Bringing Insulin Through Customs: The Border Rules for Type 1 Diabetes (2026)

Updated October 2026 ยท 9 min read

You cleared security. The plane landed. Your bag is on the carousel. Now comes the lane most diabetes guides skip: customs, the border check at the far end of arrivals. Security and customs are two different jobs, run by different people, asking different questions, and confusing them is how a smooth trip turns into a long conversation at a desk.

I have had type 1 diabetes (T1D) for 20 years and I fly with an Omnipod 5 and a Dexcom G7, a continuous glucose monitor (CGM) that reads glucose every few minutes. This guide covers only the border lane: what customs officers actually check, how much insulin counts as personal use, the paperwork that answers their questions, the red and green channels, and the verified rules for the US, the UK, Canada, Australia, Japan, and New Zealand. The checkpoint lane is covered separately in the TSA rules guide and the airport security abroad guide, and the travel letter itself is covered in the travel letter guide. This post links to those guides instead of repeating them.

Talk to your care team before any border decision that touches your medicine. This guide explains border rules, not insulin plans. Any change to your insulin type, schedule, or supplies belongs in a conversation with your care team, not in a customs hall. This guide is general information, not medical advice, and border rules change, so confirm the current rule for your destination before you travel.

1. Security is not customs: two lanes, two questions

At security, the question is safety: is anything in this bag dangerous on a plane? Officers screen for weapons and explosives, and diabetes supplies get an exemption from the usual liquid limits because they are medically necessary. At customs, the question is importation: what are you bringing into this country, is it allowed in, and is it for you?

That distinction explains why the same bag can sail through one lane and stop at the next. A security officer who waved your insulin through has not cleared it for import. A customs officer who asks about your insulin is not questioning whether it is safe on a plane. They are checking three things: that it is really yours, that the quantity fits personal use, and that it is not a commercial shipment dressed up as luggage.

The US Food and Drug Administration (FDA) defines personal importation in exactly those terms: a product not for further sale or distribution into commerce. Canada's guidance uses the same test from the other side: you are a commercial importer if you bring a product in to sell it or give it to someone else who is not under your care. Everything in this guide flows from that one distinction. Personal use passes. Resale does not.

One more lane distinction matters in the UK. The UK hand luggage rule about proof is a security rule, not a customs rule. GOV.UK says you need proof that a medicine was prescribed to you, such as a doctor's letter or a prescription copy, only when the medicine is both in liquid form and in a container larger than 100ml. Tablets need no proof, and liquid in a container of 100ml or smaller needs no proof. That proof rule governs the checkpoint. The border rules in section 5 govern the customs hall. Carry the same letter for both, but do not quote the checkpoint rule at a customs officer, or the customs rule at a checkpoint officer.

2. The personal-use quantity principle

No country publishes a single worldwide personal-use number, and any guide that gives you one is guessing. What the official sources do publish is a pattern, and the pattern is consistent enough to plan around: about 90 days, or about three months.

The US uses 90 days for foreign nationals visiting the US. Canada uses no more than a 90-day supply or a single course of treatment, whichever is less. The UK, Australia, and New Zealand each use a three month supply as the visitor limit. Japan is the outlier with a one month line and a certificate beyond it. The practical rule that fits all of them: pack for the trip, plus the standing 20 percent buffer from the how-much-insulin guide, and stop there. A quantity that covers the trip plus a delay reads as personal use. A quantity that covers a year reads as something else, and no letter fixes that reading.

Quantity is judged against your trip, not against your prescription alone. A three week trip with a three month supply is still within the published visitor limits in most of the countries below, but it invites a question that a trip-sized supply does not. If a longer stay genuinely needs more, that is the moment to check the destination's own rule before you fly, not at the desk. The country sections below name the exact limit for each destination so you can do that check in one place.

3. The documentation trio: original packaging, prescription, letter

Three documents answer almost every customs question, and they work best kept together in your carry-on, not scattered across bags:

Diabetes New Zealand adds the habit that makes the trio work across several borders. Get several copies of the customs letter, keep the original safe with your travel documents, and hand out a photocopy at each border you cross. Do not give away the original. You cannot hand the same original to two different officers, and a trip with three borders needs three copies. Photograph the letter and the prescription labels too, so a lost paper copy is an inconvenience, not a crisis.

4. Red, green, and blue: which channel, and when to declare

Many airports sort arriving passengers into channels. Green means nothing to declare. Red means goods to declare. In the European Union (EU), blue means your journey was entirely within the EU. Ireland's Revenue guidance states the split plainly: a journey beginning outside the EU uses the green channel if you have no goods to declare and the red channel if you have goods to declare, while a journey entirely within the EU uses the blue channel.

What counts as goods to declare? Austria's customs guidance lists three categories: goods not intended for personal use, goods obtained outside the EU that exceed the duty-free amounts for medicinal products and other goods, and goods subject to import prohibitions or restrictions. Personal-use insulin in a trip-sized quantity with its paperwork does not automatically land in the red channel in every country, because many countries handle medicine declarations on the arrival card instead of at a channel. New Zealand, for example, requires declaration on the incoming passenger arrival card when the quantity is over three months or the medicine is not prescribed to you. The channel system and the arrival card are two versions of the same question: are you telling the border about this, or hoping it is not noticed?

The rule that resolves every unsure case is the same in both systems. Austria's guidance says it directly: in case of doubt, declare all goods. New Zealand's regulator says it the same way: if in doubt, declare it. A declared bag gets inspected and released. An undeclared bag that gets inspected gets a different conversation, about the declaration, not just the medicine. When in doubt, walk to the red channel or the declaration desk and say what you have. It costs minutes. The alternative can cost the trip.

5. Country spotlights, verified against official sources

Each spotlight below states only what the official source read on 2026-10-27 actually says. Where a source does not cover a point, this guide says so instead of filling the gap.

United States: read the citizen and visitor lines separately

The FDA page draws a line that surprises most US travellers. For a foreign national visiting the US, the FDA says it will allow the visitor to bring or ship a 90-day supply of drug products, and if the stay runs longer than 90 days, additional medication may be sent. Mailed medication should include documentation showing it is for the visitor's own use: a copy of the visa or passport, a letter from a doctor, and a copy of the prescription in English.

For US citizens, the page is stricter, because it is about drugs bought abroad that are not approved in the US. It says importing such drugs for personal use is generally illegal, with narrow permissive factors: a serious condition with no effective domestic treatment, no commercialization or promotion to US residents, no unreasonable risk, a written affirmation that the product is for personal use, generally not more than a three month supply, and either the name and address of a US licensed doctor responsible for treatment or evidence that the product continues a treatment begun abroad. A US citizen returning home with US-prescribed insulin is not in the foreign-drug situation the citizen section describes, but the page is still the reason to carry the documentation trio: the FDA page frames its permissive factors as decisions its personnel may take case by case, and the paperwork is what makes your case easy to decide. At the border, that decision is made by the officers in front of you, officers of U.S. Customs and Border Protection (CBP), not by this guide.

United Kingdom: the letter is spelled out, and the cap is three months

The UK page is written for visitors bringing medicine into the UK. A non-UK resident needs a letter of proof that the medicine was prescribed for them, with your name, your travel dates, a list of your medicine including how much you have, the doses and the strength, and the signature of the person who prescribed your drugs. Only up to three months supply may be brought in. The page is blunt about the excess: if you bring more than three months supply, or get more medicine posted to you, it will be taken away.

Two UK cautions belong here. First, the page opens with controlled drugs: medicine containing a controlled drug may be taken away at the border if you cannot prove it was prescribed for you, and drugs in the strictest schedule need a licence from the Drug and Firearms Licensing Unit before travel. Ask your doctor or pharmacist whether any medicine you carry contains a controlled drug, and check the destination embassy's rules for every country on the itinerary, exactly as the UK page advises for travel out of the UK. Second, the three month cap is a cap, not a target. Pack for the trip plus the buffer, not for the cap.

Canada: 90 days or one course, whichever is less, plus written outcomes

Canada's Health Canada guidance defines personal use as bringing a product for your own use, for a person or animal under your care, or for a person or animal travelling with you. The quantity test is no more than a 90-day supply or a single course of treatment, whichever is less, based on the product's directions for use. Visitors entering Canada may bring a personal quantity for their own use or for a person under their care travelling with them, and visitors staying more than three months may bring an additional 90-day supply every three months by mail or courier. Visitors must be ready to provide evidence of visitor status, such as a passport copy, a student or work visa, or a letter from an employer or university.

Canada is also the country where the "what happens if it is held" question has a published answer. Canada Border Services Agency (CBSA) officers may detain a health product they suspect does not comply, Health Canada may refuse entry or seize a non-compliant product, and Health Canada will notify you in writing of the outcome of the inspection, including any notice of seizure and disposition options where they apply. Keep that written notice. It is the record you need for any follow-up, and for a travel insurance claim if your policy covers medication replacement.

Australia: the traveller's exemption, built for diabetes

Australia's Therapeutic Goods Administration (TGA) runs a traveller's exemption that covers diabetes travellers by name. The exemption allows certain medicines and medical devices into Australia for personal use, or use by an immediate family member travelling with you, without special permission. The included categories cover medicines that lower blood glucose and blood glucose monitoring devices, and the page's own diabetes case study shows a traveller with insulin in original packaging, with a prescription and a doctor's letter.

The exemption has five requirements to meet together: do not bring medicines in for anyone other than yourself or an immediate family member travelling with you, do not sell or supply the product to anyone else, keep the product in original packaging with dispensing labels if possible, carry the prescription or a doctor's letter outlining what you take and how much you are bringing, and bring no more than a three month supply. Take any remaining medicines with you when you leave Australia, and comply with customs officers' directions. It is against the law to bring medicines into Australia to give to someone else, so the companion backup pouch rule from the recovery guides stops at the border: your companion's pouch is your medicine only if it is for you, not a gift for a traveller you met on the plane.

Japan: one month without a certificate, more only with one

Japan has the strictest line in this guide, and the clearest paperwork for crossing it. The Embassy of Japan's guidance says prescription medicine may be brought in without special procedures if four conditions hold: it is only for your own use, it is not a prohibited drug, it is not an especially controlled drug, and the quantity is no more than a one month supply. More than a one month supply needs a Yakkan Shoumei, Japan's medicine import certificate, received before you leave home. For injections, only a pre-filled syringe or self-injection kit may be brought in, and more than a one month supply of an injection also needs the certificate before travel. Application documents go by post, and the certificate is sent back by post, email, or fax once the documents are complete.

Pump users need a separate check. The embassy guidance covers injections in pre-filled syringe or self-injection kit form. A pump is a device, not a syringe, and this guide could not verify from an official source that a pump falls in that category. If you use a pump and travel to Japan, contact the embassy before you travel and ask how to list the pump and its supplies on the application. Do not assume the one month injection rule covers a device it does not name.

New Zealand: declare on the card, three months, original containers

New Zealand's regulator, Medsafe, sets the rule for prescription medicines carried in on your person or in luggage, other than controlled drugs. You must declare the medicine on the incoming passenger arrival card if the quantity is over three months supply or the medicine is not prescribed to you, and you must have a copy of the prescription or a doctor's letter stating you are being treated with the medicine, carry the medicine in original containers, and keep the quantity to no more than three months supply. Medicines that are controlled drugs must be declared on the arrival card, and the quantity is limited to one month supply. The regulator closes with the same advice as Austria: if in doubt, declare it.

The EU: channels yes, one quantity number no

For the EU, this guide verifies the channels and stops there. The channel system is documented by member-state customs authorities: green for nothing to declare, red for goods to declare, blue for a journey entirely within the EU. What this guide could not verify from an official source is a single EU-wide personal-use insulin quantity, because member states apply their own medicine rules inside the shared customs framework. If your destination is inside the EU, check that country's embassy or customs page for its medicine quantity before you fly, and use the red channel or the declaration desk whenever the answer is unclear. Do not carry a quantity rule from one member state into another and assume it travels with you.

6. If an officer questions or holds your medication

Most border conversations end in minutes: the officer reads the label, reads the letter, and waves you through. When one does not, the order of operations matters more than the argument. Stay calm and polite. Show the documentation trio, starting with the labeled original packaging, then the prescription, then the letter. Answer the question asked, and only that question: what it is, whose it is, how much you have, and how long you are staying. Do not volunteer a history of your diabetes, and do not argue the officer's authority. A customs hall is not a debate stage.

Then ask for specifics, politely, and in this order. First, ask what rule is being applied to your medicine, so you know whether the issue is quantity, packaging, or documentation. Second, ask for the decision and the reason in writing. In Canada that written notice is part of the published process. Elsewhere it is a request, not a guarantee, but it is still the right request: a written reason turns a hallway conversation into a record you can act on. Third, if the conversation is in a language you do not read well, do not sign a form you cannot read or do not understand. Ask for an interpreter or a translated explanation first, and wait for it. Signing something you do not understand to end an uncomfortable conversation can create a worse problem than the delay.

If the situation escalates beyond a bag check into detention or arrest, the embassy step applies. The US State Department's guidance for arrest abroad says to ask detaining authorities to notify the US embassy or consulate, and that a consulate can provide a list of local attorneys, visit the detained citizen, and request adequate medical care. It also states the limits plainly: a consulate cannot get a citizen out of detention, provide legal advice, or represent a citizen in court. That step is for a serious escalation, not for a slow bag inspection. For a held bag, the practical next steps are the written reason, your travel insurance emergency line, and your care team's on-call line, in that order.

One rule covers every version of this conversation: never let a held bag become a missed dose decision made under pressure. If insulin is held and you have none on your body, tell the officer that plainly and ask for the fastest path to a resolution, whether that is a supervisor review, a partial release, or directions to the nearest pharmacy. If the bag is released only after a delay, check the insulin before you use it: heat and freezing damage insulin, and the hotel insulin storage guide covers the label rules for temperature and the 28-day in-use window. A vial that spent hours in an unknown environment is a question for your care team or a pharmacist, not a guess at the arrivals curb.

7. Insulin abroad: the name and the strength on the box

Border paperwork gets you in. Pharmacy reality decides what happens if you need insulin while you are there. The brand name on your box may not exist at the destination pharmacy, and the strength may differ. Write down the generic name of every insulin you use before you leave. The generic name, also called the International Nonproprietary Name (INN), is the standardized name pharmacists worldwide recognize even when the brand on the box means nothing to them.

The airport security abroad guide covers the brand-name example in full: NovoLog in the US is sold as NovoRapid in most other countries, the same insulin aspart in the box. The concentration check matters just as much. U-100 means 100 units per milliliter, the standard concentration on US insulin labels. Diabetes New Zealand warns travellers to check the strength of any insulin obtained overseas because some countries market different strength insulin. Read the concentration printed on the foreign box, compare it to your prescription, and confirm it with the pharmacist before you use it. Any change to your insulin type or schedule is a care-team conversation, never a pharmacy-counter guess, and a substitute insulin is not a reason to skip the border paperwork on the way home either.

8. If you run out abroad, do not re-solve it at the border

Running out abroad is a pharmacy problem, not a customs problem, and this guide does not re-explain it. The call order is in the lost or stolen recovery playbook: home pharmacy transfer, care-team on-call line, telehealth visit, device manufacturer, then the local pharmacy with your prescription photos and generic names. The international travel guide covers the rest of the abroad paperwork, including the local emergency number and the nearest hospital to your stay. The border lesson from that scenario is simpler: the 20 percent buffer exists so a delay never becomes a pharmacy run, and a pharmacy run never becomes a border problem on the way home with unfamiliar boxes.

Packing for a trip that crosses a border? Our free calculator builds a personalized supply list based on your insulin type and exact trip length, with a 20% safety buffer built in. Trip-sized quantities, plus the buffer, are what the personal-use rules above are written for. Build My Packing List

The customs checklist

Here is the full border routine, in order:

  1. Before you fly, check the destination's own medicine quantity rule on its embassy or customs page, and note whether it is 90 days, three months, or Japan's one month line.
  2. Pack for the trip plus 20 percent, never for the cap, and never in a quantity that reads as stock for resale.
  3. Keep insulin and supplies in original packaging with pharmacy labels showing your name, in your carry-on, never in checked luggage.
  4. Carry the documentation trio together: original packaging, a prescription copy matching your passport name, and a doctor's letter with your name, travel dates, medicine list with quantities, and prescriber signature.
  5. Photocopy the letter for each border you will cross, keep the original safe with your travel documents, and photograph the letter and prescription labels as backup.
  6. For Japan over one month, get the Yakkan Shoumei before you leave home; for a pump trip to Japan, ask the embassy how to list the device first.
  7. At arrivals, declare on the card when asked, and use the red channel or declaration desk whenever you are unsure; green means nothing to declare.
  8. If questioned, stay calm, show the trio, answer only the question asked, ask what rule is being applied, and ask for the decision in writing.
  9. Do not sign a form you cannot read or do not understand; ask for an interpreter or a translated explanation first.
  10. Keep sugar packets in your pocket through the border hall: 1 packet at 60 to 70, 2 below 60, so a slow inspection never becomes an untreated low.
  11. Abroad, write down the generic name of each insulin, check the concentration on any foreign box against your prescription, and confirm it with the pharmacist.
  12. If a bag is held or lost, use the recovery playbook call order, and bring any written seizure or inspection notice to your care team and your insurer.

Customs is the last lane of the trip, and the easiest to prepare for, because it asks the same three questions everywhere: is it yours, is it personal use, and can you prove both? Answer those three before you leave home, and the border hall becomes what it should be: a short walk to the exit, not a story you tell later. The travel letter guide is the companion piece for the letter itself, and the airport security abroad guide is the companion piece for the checkpoint that comes before it.

Frequently Asked Questions

Q: Do I need to declare insulin at customs?

A: Declare it when the arrival form asks, when the country requires it, or whenever you are unsure. Personal-use insulin in a reasonable quantity with its prescription and letter is a normal declaration, not a confession. Austria's customs guidance says it plainly: in case of doubt, declare all goods. A green channel means nothing to declare, and a red channel means goods to declare, so an unsure traveller belongs in the red channel or at the declaration desk, not in the green channel hoping for the best.

Q: How much insulin counts as personal use at a border?

A: There is no single worldwide number, but the pattern repeats across the official sources: about 90 days, or about three months. The US Food and Drug Administration uses a 90-day supply for foreign nationals visiting the US. Canada's guidance uses no more than a 90-day supply or a single course of treatment, whichever is less. The UK, Australia, and New Zealand each use a three month supply as the visitor limit. Japan is the exception that proves the rule: one month without a certificate, more only with a Yakkan Shoumei. Pack for the trip plus the 20 percent buffer, and never pack a quantity that looks like stock for resale.

Q: What paperwork should I carry at the border?

A: Three things, kept together in your carry-on: insulin and supplies in original packaging with pharmacy labels, a copy of your prescription, and a doctor's letter stating you have diabetes and listing what you carry. Diabetes New Zealand adds the habit that makes the trio work across several borders: keep the original letter safe with your travel documents and hand out photocopies, one for each border, because you cannot hand the same original to two different officers. The letter should name you as your passport does, list each insulin and device, and carry your prescriber's signature.

Q: Do I need a Yakkan Shoumei to bring insulin into Japan?

A: Only if you cross Japan's one month line. The Embassy of Japan's guidance says prescription medicine may be brought in without special procedures if it is only for your own use, is not a prohibited or especially controlled drug, and is no more than a one month supply. More than a one month supply needs a Yakkan Shoumei, Japan's medicine import certificate, received before you leave home. For injections, only a pre-filled syringe or self-injection kit may be brought in, and more than a one month supply of an injection also needs the certificate before travel. If you use a pump, check with the embassy before you travel, because the guidance covers injections in those forms and a pump is a device, not a syringe.

Q: What happens if a customs officer questions or holds my insulin?

A: Stay calm, show the documentation trio, and ask what rule is being applied and for the decision in writing. Do not sign a form you cannot read or do not understand; ask for an interpreter or a translated explanation first. In Canada, Health Canada's guidance says you will be notified in writing of the outcome of an inspection, including any notice of seizure, so a written record is part of that system. If the situation escalates beyond a bag check, ask detaining authorities to notify your country's embassy or consulate: a consulate can provide a list of local attorneys, visit you, and request adequate medical care, but it cannot get you out of detention or act as your lawyer.

Q: What if my insulin has a different name or strength abroad?

A: Write down the generic name of your insulin before you leave. The generic name, also called the International Nonproprietary Name (INN), is the standardized name pharmacists worldwide recognize even when the brand on the box means nothing to them. The airport security abroad guide covers the brand-name example: NovoLog in the US is sold as NovoRapid in most other countries, the same insulin aspart in the box. Also check the concentration printed on the box against your prescription. U-100 means 100 units per milliliter, and Diabetes New Zealand warns travellers to check the strength of any insulin obtained overseas because some countries market different strength insulin. Any change to your insulin type or schedule is a care-team conversation, never a pharmacy-counter guess.

General guidance only, not medical advice. Your insulin type, schedule, and supplies are conversations with your care team, ideally before your next trip. Border rules, medicine classifications, and quantity limits change, so confirm the current rules for your destination with its embassy or customs authority before you travel. If you have a severe low or suspected diabetic ketoacidosis (DKA, the emergency where ketones build up because the body cannot use glucose) on a trip, get medical help and tell your care team afterward.

Additional Details